Dashboard
Manage Tickers

VSTM


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

verastem-oncology-to-present-late-breaking-abstract-of-the-mature-data-from-the-ongoing-phase-2-ramp-201-clinical-trial-at-igcs-annual-meeting
Verastem Oncology To Present Late-breaking...
09/10/2024 11:50:30

truist-securities-maintains-buy-on-verastem-lowers-price-target-to-15
Truist Securities Maintains Buy on Veraste...
08/13/2024 14:21:18

Truist Securities analyst Srikripa Devarakonda maintains Verastem (NASDAQ:VSTM) with a Buy and lowers the price target from ...

hc-wainwright--co-maintains-buy-on-verastem-lowers-price-target-to-7
HC Wainwright & Co. Maintains Buy on Veras...
08/12/2024 17:32:15

HC Wainwright & Co. analyst Sean Lee maintains Verastem (NASDAQ:VSTM) with a Buy and lowers the price target from $17.5 ...

rbc-capital-maintains-outperform-on-verastem-lowers-price-target-to-13
RBC Capital Maintains Outperform on Verast...
08/09/2024 19:52:09

RBC Capital analyst Gregory Renza maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $16 to...

verastem-q2-adj-061-beats-095-estimate-sales-1000k-miss-5000k-estimate
Verastem Q2 Adj $(0.61) Beats $(0.95) Esti...
08/08/2024 21:18:51

Verastem (NASDAQ:VSTM) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.95) by 3...

verastem-oncology-receives-fda-orphan-drug-designation-for-avutometinib-and-defactinib-for-the-treatment-of-pancreatic-cancer-expects-to-report-updated-data-from-the-ongoing-ramp-205-trial-in-first-line-metastatic-pancreatic-cancer-in-q1-2025
Verastem Oncology Receives FDA Orphan Drug...
07/29/2024 20:08:55

Expect to report updated data from the ongoing RAMP 205 trial in first-line metastatic pancreatic cancer in Q1 2025Verastem Onc...

why-general-dynamics-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why General Dynamics Shares Are Trading Lo...
07/24/2024 17:26:11

why-enphase-energy-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Enphase Energy Shares Are Trading High...
07/24/2024 09:27:11

reported-earlier-verastem-oncology-prices-55m-public-offering-of-13333334-common-stock-warrants-and-pre-funded-warrants
Reported Earlier, Verastem Oncology Prices...
07/24/2024 06:45:25

Verastem Oncology, (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, to...

verastem-oncology-announces-proposed-public-offering-of-common-stock-warrants-and-pre-funded-warrants-no-size-or-amount-disclosed
Verastem Oncology Announces Proposed Publi...
07/23/2024 20:12:23

Verastem Oncology, (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, to...

why-asp-isotopes-shares-are-trading-lower-by-9-here-are-other-stocks-moving-in-fridays-mid-day-session
Why ASP Isotopes Shares Are Trading Lower ...
07/12/2024 17:14:56

verastem-oncology-reveals-first-patient-dosed-with-gfh375vs-7375-a-kras-g12d-onoff-inhibitor-in-a-phase-12-trial-in-china-as-part-of-collaboration-with-genfleet-therapeutics
Verastem Oncology Reveals First Patient Do...
07/12/2024 11:33:04

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced t...

truist-securities-maintains-buy-on-verastem-lowers-price-target-to-18
Truist Securities Maintains Buy on Veraste...
07/08/2024 15:43:40

Truist Securities analyst Srikripa Devarakonda maintains Verastem (NASDAQ:VSTM) with a Buy and lowers the price target from ...

reported-wednesday-chinas-nmpa-approves-genfleet-and-verastem-oncologys-gfh375-for-kras-g12d-phase-iii-trials
Reported Wednesday, China's NMPA Approves ...
06/20/2024 09:45:47

 GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, a...

alliance-global-partners-maintains-buy-on-verastem-lowers-price-target-to-20
Alliance Global Partners Maintains Buy on ...
05/29/2024 16:55:51

Alliance Global Partners analyst Jeff Grampp maintains Verastem (NASDAQ:VSTM) with a Buy and lowers the price target from $3...

rbc-capital-maintains-outperform-on-verastem-lowers-price-target-to-16
RBC Capital Maintains Outperform on Verast...
05/28/2024 12:11:57

RBC Capital analyst Gregory Renza maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $32 to...

hc-wainwright--co-reiterates-buy-on-verastem-maintains-175-price-target
HC Wainwright & Co. Reiterates Buy on Vera...
05/28/2024 10:45:18

HC Wainwright & Co. analyst Sean Lee reiterates Verastem (NASDAQ:VSTM) with a Buy and maintains $17.5 price target.

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/27/2024 16:31:22

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/27/2024 12:05:50

crude-oil-rises-1-verastem-shares-slide
Crude Oil Rises 1%; Verastem Shares Slide
05/24/2024 18:47:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION